Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
S/GSK1265744
print preview
bookmark
share with colleague
General Information
Company
GlaxoSmithKline plc
Description
Long-acting parenteral integrase inhibitor
Molecular Target
Mechanism of Action
HIV integrase inhibitor
Latest Stage of Development
Phase II
Indication
HIV / AIDS
Partner
Shionogi & Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy